FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TELAZORLIMAB
异名/同义词GBR 830
GBR830
GBR-830
HUMANIZED MONOCLONAL ANTIBODY ISB 830
HUMANIZED, IMMUNOGLOBIN G1(IGG1) ANTIBODY SPECIFIC FOR OX40 (CD134)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL GBR 830 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GBR 830 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL ISB 830 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ISB 830 .KAPPA.-CHAIN, DIMER
ISB 830
ISB-830
TELAZORLIMAB
TELAZORLIMAB [INN]
TELAZORLIMAB [WHO-DD]
CAS登记号2126777-87-3
物质唯一标识(Unique Ingredient Identifier)0CRN540O4R
分子式11273
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 /
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System